Spyre Therapeutics Inc（SYRE）の株価予測SYRESpyre Therapeutics Inc

Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $94.75 (-1.87%). The 1-week path is $88.27 (-8.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Spyre Therapeutics Inc (SYRE) is a good buy right now due to its current price of $90.33, which is significantly lower than the average analyst price target of $123, suggesting a potential upside of approximately 36%. The stock has shown impressive performance with a year-to-date change of +195.39% and a one-year change of +267.64%, indicating strong momentum. However, the company is facing risks with a high insider selling percentage of 796.31% over the last month, which could signal caution. Overall, the positive clinical trial results and strong analyst support outweigh the risks, making it a favorable investment opportunity for long-term investors.

Spyre Therapeutics Inc (SYRE) last closed at $96.5599976, losing -2.43%. These facts feed the 1-day and 1-week SYRE price prediction above.